Literature DB >> 33807548

CFTR Cooperative Cis-Regulatory Elements in Intestinal Cells.

Mégane Collobert1, Ozvan Bocher1, Anaïs Le Nabec1, Emmanuelle Génin1, Claude Férec1,2, Stéphanie Moisan1,2.   

Abstract

About 8% of the human genome is covered with candidate cis-regulatory elements (cCREs). Disruptions of CREs, described as "cis-ruptions" have been identified as being involved in various genetic diseases. Thanks to the development of chromatin conformation study techniques, several long-range cystic fibrosis transmembrane conductance regulator (CFTR) regulatory elements were identified, but the regulatory mechanisms of the CFTR gene have yet to be fully elucidated. The aim of this work is to improve our knowledge of the CFTR gene regulation, and to identity factors that could impact the CFTR gene expression, and potentially account for the variability of the clinical presentation of cystic fibrosis as well as CFTR-related disorders. Here, we apply the robust GWAS3D score to determine which of the CFTR introns could be involved in gene regulation. This approach highlights four particular CFTR introns of interest. Using reporter gene constructs in intestinal cells, we show that two new introns display strong cooperative effects in intestinal cells. Chromatin immunoprecipitation analyses further demonstrate fixation of transcription factors network. These results provide new insights into our understanding of the CFTR gene regulation and allow us to suggest a 3D CFTR locus structure in intestinal cells. A better understand of regulation mechanisms of the CFTR gene could elucidate cases of patients where the phenotype is not yet explained by the genotype. This would thus help in better diagnosis and therefore better management. These cis-acting regions may be a therapeutic challenge that could lead to the development of specific molecules capable of modulating gene expression in the future.

Entities:  

Keywords:  3D structure; CFTR; cis-ruption disorders; regulation; transcription factors

Mesh:

Substances:

Year:  2021        PMID: 33807548      PMCID: PMC7961337          DOI: 10.3390/ijms22052599

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  67 in total

1.  Triphalangeal thumb-polysyndactyly syndrome and syndactyly type IV are caused by genomic duplications involving the long range, limb-specific SHH enhancer.

Authors:  M Sun; F Ma; X Zeng; Q Liu; X-L Zhao; F-X Wu; G-P Wu; Z-F Zhang; B Gu; Y-F Zhao; S-H Tian; B Lin; X-Y Kong; X-L Zhang; W Yang; W H-Y Lo; X Zhang
Journal:  J Med Genet       Date:  2008-04-16       Impact factor: 6.318

2.  Genetic modifiers of lung disease in cystic fibrosis.

Authors:  Mitchell L Drumm; Michael W Konstan; Mark D Schluchter; Allison Handler; Rhonda Pace; Fei Zou; Maimoona Zariwala; David Fargo; Airong Xu; John M Dunn; Rebecca J Darrah; Ruslan Dorfman; Andrew J Sandford; Mary Corey; Julian Zielenski; Peter Durie; Katrina Goddard; James R Yankaskas; Fred A Wright; Michael R Knowles
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

3.  Transcriptional networks driving enhancer function in the CFTR gene.

Authors:  Jenny L Kerschner; Ann Harris
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

4.  Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene.

Authors:  Nele Gheldof; Emily M Smith; Tomoko M Tabuchi; Christoph M Koch; Ian Dunham; John A Stamatoyannopoulos; Job Dekker
Journal:  Nucleic Acids Res       Date:  2010-03-31       Impact factor: 16.971

5.  Molecular mechanisms controlling CFTR gene expression in the airway.

Authors:  Zhaolin Zhang; Christopher J Ott; Marzena A Lewandowska; Shih-Hsing Leir; Ann Harris
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

6.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

Review 7.  Cell-Selective Regulation of CFTR Gene Expression: Relevance to Gene Editing Therapeutics.

Authors:  Hannah Swahn; Ann Harris
Journal:  Genes (Basel)       Date:  2019-03-19       Impact factor: 4.096

Review 8.  Long-range control of gene expression: emerging mechanisms and disruption in disease.

Authors:  Dirk A Kleinjan; Veronica van Heyningen
Journal:  Am J Hum Genet       Date:  2004-11-17       Impact factor: 11.025

9.  Nucleosome mapping across the CFTR locus identifies novel regulatory factors.

Authors:  Erbay Yigit; Jared M Bischof; Zhaolin Zhang; Christopher J Ott; Jenny L Kerschner; Shih-Hsing Leir; Elsy Buitrago-Delgado; Quanwei Zhang; Ji-Ping Z Wang; Jonathan Widom; Ann Harris
Journal:  Nucleic Acids Res       Date:  2013-01-15       Impact factor: 16.971

10.  Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.

Authors:  Harriet Corvol; Scott M Blackman; Pierre-Yves Boëlle; Paul J Gallins; Rhonda G Pace; Jaclyn R Stonebraker; Frank J Accurso; Annick Clement; Joseph M Collaco; Hong Dang; Anthony T Dang; Arianna Franca; Jiafen Gong; Loic Guillot; Katherine Keenan; Weili Li; Fan Lin; Michael V Patrone; Karen S Raraigh; Lei Sun; Yi-Hui Zhou; Wanda K O'Neal; Marci K Sontag; Hara Levy; Peter R Durie; Johanna M Rommens; Mitchell L Drumm; Fred A Wright; Lisa J Strug; Garry R Cutting; Michael R Knowles
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

View more
  1 in total

Review 1.  CFTR and Gastrointestinal Cancers: An Update.

Authors:  Rahul Bhattacharya; Zachary Blankenheim; Patricia M Scott; Robert T Cormier
Journal:  J Pers Med       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.